GENERAL INCEPTION — Full Portfolio

Biocellis develops a patented bioluminescence immunoassay platform that delivers laboratory-grade, picogram-level sensitivity with results in under 60 seconds in a compact, portable format for point-of-care and high-throughput screening.

BiotechDeep TechMedical DevicesGrenoble, FR

VPVincent Poher(Co-founder)inThierry Rose(Co-founder)Sophie Goyard(Co-founder)

Inapill develops first-in-class, orally available small-molecule therapeutics that target immune cell metabolism to suppress multiple pro-inflammatory cytokines at once.

BiotechDeep TechHealthtech

GTGreg Timblin(Founder & CEO)inEric Noel(Head of Operations)Kathleen Pestal(Head of Research)

BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms.

AI & Machine LearningBiotechDigital HealthMedical DevicesHouston, US

SWSteve Wallace(Chief Operating Officer, Global Supply Chain Management)inDJDonna J. Edmonds(CEO)inJVJames V. Snider(Chief Technology Officer / Advisor)TVTim Van Meter(Chief Scientific Officer)RNRichard Noel(Chief Product and Commercial Officer)inRobert Sledd(Director)

Board seatVCVikram Chaudhery· per SEC Form D · $18.5M raise · filed Nov 2023

Co-investorsAMAmbit Health VenturesBIBioventures InvestorsGEGenoa VenturesVTVTC Ventures

Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.

BiotechDeep TechBerkeley, US

DEDaniel Estandian(Founder)inEd Boyden(Founder)JYJosh Yang(Founder)in

BoardJimmy Yun(Director)in

Board seatCraig Asher· per SEC Form D · $52.9M raise · filed Feb 2024

Co-investorsARArtis VenturesBLBlack FlagCICivilization Ventures Management, LlcFOFoundersX VenturesHAHarpoon VenturesLOLongeVC+5 more

SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.

AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US

JPJoe Peterson(Co-founder)John Cole(Co-founder)TPTushar Pandey(Co-founder)inSSStacey Stevens(Executive Officer, Director)in

BoardLCLucy Coassin(Director)

Board seatVCVikram Chaudhery· per SEC Form D · $8M raise · filed Jan 2025

Co-investorsAVAV8 VenturesGEGenoa VenturesNONorthpond Ventures

Abbelight provides microscopy equipment, reagents, and services to researchers and biotech labs for studying biology at the molecular level.

BiotechDeep TechHardwareMedical Devices

JMJean-Baptiste Marie(CEO and Co-founder)inNBNicolas Bourg(CTO and Co-founder)in

BoardSandrine Lévèque-Fort(Scientific Advisor)Emmanuel Fort(Scientific Advisor)

Co-investorsAVAvant BioDYDynamk Capital

Alida Biosciences develops tools for RNA modification detection and analysis that enable research and diagnostic applications across drug discovery, clinical testing, and biotechnology.

AI & Machine LearningBiotechData & InfrastructureDeep TechHealthtechSan Diego, US

BPByron Purse(Co-Founder)inJDJohn Drewry(Director)inGudrun Stengel(CEO & Co-Founder)

Co-investorsFUFusionX VenturesVEVertical Venture PartnersPAPaladin Capital Group

Axoiya Bio develops phosphotyrosine enrichment reagents using proprietary superbinder technology to detect rare, low-abundance phosphorylation events for deeper phosphoproteome coverage.

BiotechDeep Tech

Basilard BioTech develops Celletto, a nanomechanical (mechanoporation) gene delivery platform that inserts genes directly into the nucleus of cells without viral vectors, aimed at cell and gene therapy (CGT) developers and manufacturers.

BiotechDeep TechMedical Devices

Co-investorsBABand of AngelsPAPaladin Capital GroupVEVertical Venture Partners

Clearcut Surgical develops a surgical device that combines electrosurgery, continuous smoke evacuation, and on-demand fluid suction in a single instrument.

HardwareHealthtechMedical DevicesBoston, US

AYAlex Yang(MD)inHeung Bae Kim(MD)Jeffery John Caputo(Executive Officer, Director)

Co-investorsLALaunchpad Venture GroupMAMassVentures

Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured.

BiotechDeep TechNew Materials

JCJason Chin(Professor)

Co-investors+N+ND CapitalAMAmadeus Capital PartnersFIFine Structures VenturesLOLongeVCOMOMX VenturesPAPaladin Capital Group+3 more

CryoVeritas makes user-activated temperature indicators that integrate both time and temperature to confirm the integrity of vaccines and biospecimens exposed to heat during cold-chain storage down to −200 °C.

BiotechHardwareHealthtech

Co-investorsPAPaladin Capital Group

Detective Biosciences is developing a blood-based cancer detection test that analyzes patients' DNA epigenetic profiles.

BiotechHealthtechMedical Devices

Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases.

AI & Machine LearningBiotechWatertown, US

EKEric Kelsic(CEO & Cofounder)inSSSam Sinai(Vice President, Head of ML & Cofounder)inAVAdrian Veres(Chief Scientific Officer & Cofounder)inGCGeorge Church(Scientific Cofounder, SAB)inTBTomas Bjorklund(Scientific Co-founder, SAB)inACAlan Crane(Executive Chairman & Cofounder, Polaris Entrepreneur Partner)

Co-investorsANAndreessen HorowitzCRCRV (Charles River Ventures)GVGV (Google Ventures)LULux CapitalOBObvious VenturesCACasdin Capital+2 more

Eleni Health develops medical devices for female pelvic health treatment, combining neuromodulation and digital health technologies.

Digital HealthFemTechMedical Devices

Stephanie Prendergast(CEO & Co-founder)

Ennovate Pharma is an early-stage biotech company developing personalized therapeutic antibodies for autoimmune and inflammatory diseases, focusing on refractory and non-responder patients of current cytokine-based treatments.

AI & Machine LearningBiotechMedical DevicesSaint-Louis, FR

Exodigm develops extracellular organic sensors that monitor the intracellular genomic and transcriptomic content of living cells, allowing researchers to select, track, and study specific cells by their genomic content.

BiotechDeep TechMedical Devices

Hao Yan(Co-founder)Rizal Hariadi(Co-founder)

Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.

BiotechDeep TechMedical Devices

Co-investorsPAPaladin Capital GroupGEGenoa Ventures

Jounce Therapeutics was a Cambridge, MA clinical-stage biopharmaceutical company developing cancer immunotherapies, including antibodies targeting ICOS and LILRB2/ILT4, guided by a biomarker-driven discovery platform.

BiotechCambridge, US

KCKim C. Drapkin(Executive Officer)Anna L. Barry(Executive Officer)inRMRichard Murray(Executive Officer, Director)

BoardRTRobert Tepper(Director)inCPCary Pfeffer(Director)inRobert Kamen(Director)in

Co-investorsBOBoutique Venture PartnersNENextech InvestSOSofinnova VenturesVEVenture Capital Investment ManagementTHThird Rock Ventures

Kindbody is a fertility care provider offering services such as egg freezing, IVF, IUI, and prenatal and gynecological care through its own clinics across the US.

Digital HealthFemTechHealthtechSan Francisco, US

DLDr. Lynn Westphal(Co-founder)GBGina Bartasi(Executive Officer, Director)inFSFahimeh Sasan(Founding Physician / Ob-Gyn)inABAngeline Beltsos, M.D.(Director)

BoardKHKathy Harris(Director)inCheryl Pegus(Director)

Co-investorsANAnsa CapitalCLClaritas CapitalGVGV (Google Ventures)SPSpice CapitalTMTMVTQTq Ventures Llc+3 more

KOMO Biosciences develops genome engineering technology based on hyperactive large serine integrases to transform cell-based manufacturing of biologics and advanced therapies.

BiotechDeep Tech

Jennifer Manning(Founder & CEO)inTPThomas Page(Acting CTO)inMFMatt Farabaugh(Acting CFO)JBJesse B. Owens(Acting CSA)in

BoardRay Tabibiazar(Chairman of the Board)in

Co-investorsGEGenesis BioCapitalESEshelman Ventures, LLCMOModi VenturesLDLDV Partners

Origin Peptides develops an environmentally efficient process for peptide synthesis using aqueous, single-pot reactions that eliminate the need for hazardous organic solvents.

BiotechCleantechDeep TechNew Materials

Dr Sara ten Have(Founder, CSO)Gary Buchanan(Founder, COO)

Partillion generates cell-cell interaction data using Nanovials that co-localize cells in defined microenvironments to measure signaling, activation, binding, and other responses, with live-cell recovery via standard flow cytometry.

AI & Machine LearningBiotechDeep TechLos Angeles, US

DDDino Di Carlo(Director)inJDJoe de Rutte(Founder)inEMEric Moessinger(Director)in

BoardPCPaul Conley(Director)in

Co-investors+N+ND CapitalPAPaladin Capital GroupVEVertical Venture Partners

Pharmacelera develops computational chemistry software and services for drug discovery, using proprietary 3D molecular field descriptors, quantum mechanics, and AI to screen ultra-large chemical libraries and identify novel, synthesizable compounds.

AI & Machine LearningBiotechDeep TechBarcelona, ES

EGEnric Gibert(Founder)inEHEnric Herrero(Founder)in

Co-investorsCACapital CellHEHeran Partners

Planet Smart develops PlanetSorb, a fully compostable, bio-based superabsorbent polymer designed to replace fossil-based materials in hygiene products like diapers and menstrual pads.

Circular EconomyCleantechImpact & Social GoodNew Materials

GeraldMaurice

Roxbiosens develops sequencing-independent tools that analyze complex ecosystems such as the gut microbiome by measuring their bioenergetic status.

BiotechDeep TechDigital Health

sCellgen develops tools for epigenomics research, focused on multiplexed analysis of chromatin modifications and gene expression at the single-cell level.

BiotechDeep TechHealthtech

Surf Therapeutics develops a non-invasive broad-beam ultrasound platform that stimulates nerves to activate the body's cholinergic anti-inflammatory pathway, aiming to restore immune balance and treat inflammatory and autoimmune disorders without drugs.

Deep TechHealthtechMedical Devices

Co-investorsCACapital FactoryTMTMC Venture FundSOSOSVVVVVP Ignite

SynthBiome designs synthetic growth media that replicate the physiological conditions bacterial pathogens encounter in human infection sites, including media mimicking cystic fibrosis sputum and chronic wound environments.

BiotechDeep TechHealthtech

Sam Brown(Founder)in

Tactile Therapeutics is a venture-funded biotechnology company working on Targeted Protein Degradation.

Biotech

Tavira Therapeutics develops an AAV delivery platform for gene therapy that uses modular, post-manufacture enzymatic modification of AAV vectors to target intended tissues more accurately.

BiotechDeep TechMedical Devices

EHEls Henckaerts(Co-founder)BMBenjamien Moeyaert(Co-founder)inVeronick Benoy(Co-founder)inVKVibha Kiran Tamboli(Co-founder)IVInge Van Hove(Co-founder)in

Trench Therapeutics develops live biotherapeutic products derived from research on the nasal microbiome to prevent and treat infectious and inflammatory diseases.

BiotechHealthtech

Cindy Liu(Co-founder)David Harburger(Co-founder)Prashant Girinath(Co-founder)

Wespran develops biotechnology that converts industrial CO2 emissions into valuable chemicals like green methanol using engineered enzymes, serving heavy industries such as refineries and steel plants.

BiotechCleantechClimate TechDeep Tech

XEra Energy develops separation and purification methods for processing critical minerals and recycling lithium-ion batteries, targeting regions with gaps in scalable, profitable processing capabilities.

Circular EconomyCleantechDeep TechEnergyNew MaterialsSan Francisco, US

Dr. Haixia Deng(Founder & CEO)Dr. Wenlong Yao(COO-Founding Member)